Volume 16 (6); 2025
Research Papers
Characterization of lncRNA-Driven Networks in Portal Vein Tumor Thrombosis: Implications for Hepatocellular Carcinoma Progression
Ji Young Kim, So Hee Dho, Lark Kyun Kim
J. Cancer 2025; 16(6): 1754-1767. doi:10.7150/jca.107270
Full text
PDF
System Analysis Identifies MYBL2 As a Novel Oncogene Target for Metastatic Prostate Cancer
Renlun Huang, Jing Li, Jiawei Zhu, Wei Deng, Zhichao Wang, Songtao Xiang
J. Cancer 2025; 16(6): 1768-1781. doi:10.7150/jca.107232
Full text
PDF
Multi-omics analysis reveals lysosome-associated molecular subtype characterization and prognostic modeling system in lung adenocarcinoma
Zhanmei Wang, Yan Wang, Jinxiang Wang
J. Cancer 2025; 16(6): 1794-1813. doi:10.7150/jca.105351
Full text
PDF
Identification of GPX3 and JUN as Tumor Suppressors in Thyroid Cancer through Integrated WGCNA and Mendelian Randomization
Renjie Zhang, Yutao Chen, Sha Xu, Xue Gu, Hui Ye
J. Cancer 2025; 16(6): 1814-1831. doi:10.7150/jca.104687
Full text
PDF
Review
Oncolytic Virus Therapy in a New Era of Immunotherapy, Enhanced by Combination with Existing Anticancer Therapies: Turn up the Heat!
Emily Charlotte Fretwell, Annwyne Houldsworth
J. Cancer 2025; 16(6): 1782-1793. doi:10.7150/jca.102285
Full text
PDF
Commentary
Drugging the tumor microenvironment epigenome for therapeutic interventions in NSCLC
Kostas A. Papavassiliou, Amalia A. Sofianidi, Vassiliki A. Gogou, Athanasios G. Papavassiliou
J. Cancer 2025; 16(6): 1832-1835. doi:10.7150/jca.111023
Full text
PDF